TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS National Pharmaceuticals Transition 2022_2

Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS National Pharmaceuticals Transition 2022_2". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
46.5Bids / Report
6.4% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 881 active published awards; 872 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published4 Nov 2022, 11:18 GMT
Last source update4 Nov 2022, 11:18 GMT
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
UK
OCIDocds-h6vhtk-03538e
What is being bought
Invitation to offer for NHS National Pharmaceuticals Transition 2022_2<br/>Offer reference number: CM/PHG/22/5655<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/>Transition: CESW: 01/12/2022 to 30/09/2023 (10 months)<br/>LSNE: 01/12/2022 to 31/05/2024 (18 months)<br/>NWLN: 01/12/2022 to 31/05/2023 (6 months)
What changed
From the official release history
  1. Status changed to complete
    4 Nov 2022, 11:18 GMT
  2. Official notice release published
    4 Nov 2022, 11:18 GMT
  3. Buyer information updated
    4 Nov 2022, 11:18 GMT
  4. tender value changed
    26 Jul 2022, 16:38 BST
  5. Status changed to published status
    26 Jul 2022, 16:38 BST
  6. Official notice release published
    26 Jul 2022, 16:38 BST
  7. Submission deadline changed to published date
    26 Jul 2022, 16:38 BST
  8. Published value updated to £267,740,679
    19 Jul 2022, 16:12 BST
  9. Status changed to active
    19 Jul 2022, 16:12 BST
  10. Official notice release published
    19 Jul 2022, 16:12 BST
  11. Submission deadline changed to 23 Aug 2022, 13:00 BST
    19 Jul 2022, 16:12 BST
  12. Buyer information updated
    19 Jul 2022, 16:12 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    Invitation to offer for NHS National Pharmaceuticals Transition 2022_2<br/>Offer reference number: CM/PHG/22/5655<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/>Transition:<br/>CESW: 01/12/2022 to 30/09/2023 (10 months)<br/>LSNE: 01/12/2022 to 31/05/2024 (18 months)<br/>NWLN: 01/12/2022 to 31/05/2023 (6 months)
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    4 Nov 2022, 11:18 GMT
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Award active
    Not published · Not published
  11. Award active
    Not published · Not published
  12. Award active
    Not published · Not published
  13. Award active
    Not published · Not published
  14. Award active
    Not published · Not published
  15. Award active
    Not published · Not published
  16. Award active
    Not published · Not published
  17. Award active
    Not published · Not published
  18. Award active
    Not published · Not published
  19. Award active
    Not published · Not published
  20. Contract active
    Signed 1 Nov 2022, 00:00 GMT · £1
  21. Contract active
    Signed 1 Nov 2022, 00:00 GMT · £1
  22. Contract active
    Signed 1 Nov 2022, 00:00 GMT · £1
  23. Contract active
    Signed 1 Nov 2022, 00:00 GMT · £1
  24. Contract active
    Signed 1 Nov 2022, 00:00 GMT · £1
  25. Contract active
    Signed 1 Nov 2022, 00:00 GMT · £1
  26. Contract active
    Signed 1 Nov 2022, 00:00 GMT · £1
  27. Contract active
    Signed 1 Nov 2022, 00:00 GMT · £1
  28. Contract active
    Signed 1 Nov 2022, 00:00 GMT · £1
  29. Contract active
    Signed 1 Nov 2022, 00:00 GMT · £1
  30. Contract active
    Signed 1 Nov 2022, 00:00 GMT · £1
  31. Contract active
    Signed 1 Nov 2022, 00:00 GMT · £1
  32. Contract active
    Signed 1 Nov 2022, 00:00 GMT · £1
  33. Contract active
    Signed 1 Nov 2022, 00:00 GMT · £1
  34. Contract active
    Signed 1 Nov 2022, 00:00 GMT · £1
  35. Contract active
    Signed 1 Nov 2022, 00:00 GMT · £1
  36. Contract active
    Signed 1 Nov 2022, 00:00 GMT · £1
  37. Contract active
    Signed 1 Nov 2022, 00:00 GMT · £1
Commercial outcome and competition
Awards
Colonis Pharma Ltd
Not published · Not published · active
Glenmark Pharmaceuticals Europe Limited
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Takeda UK Ltd
Not published · Not published · active
Selective Supplies Ltd.
Not published · Not published · active
Aspire Pharma Limited
Not published · Not published · active
Pfizer Ltd
Not published · Not published · active
Ascend Laboratories UK Ltd
Not published · Not published · active
Cipla
Not published · Not published · active
Teva UK Limited
Not published · Not published · active
Thornton and Ross Ltd
Not published · Not published · active
Wockhardt UK Limited
Not published · Not published · active
Mylan
Not published · Not published · active
Gerot Lannach UK Ltd
Not published · Not published · active
Morningside Pharmaeuticals
Not published · Not published · active
Amarox Limited
Not published · Not published · active
Dr.Reddy's Laboratories (UK) Limited
Not published · Not published · active
Milpharm Ltd/aurobinbdo
Not published · Not published · active
Contracts
Contract
£1 · signed 1 Nov 2022, 00:00 GMT · active
Contract
£1 · signed 1 Nov 2022, 00:00 GMT · active
Contract
£1 · signed 1 Nov 2022, 00:00 GMT · active
Contract
£1 · signed 1 Nov 2022, 00:00 GMT · active
Contract
£1 · signed 1 Nov 2022, 00:00 GMT · active
Contract
£1 · signed 1 Nov 2022, 00:00 GMT · active
Contract
£1 · signed 1 Nov 2022, 00:00 GMT · active
Contract
£1 · signed 1 Nov 2022, 00:00 GMT · active
Contract
£1 · signed 1 Nov 2022, 00:00 GMT · active
Contract
£1 · signed 1 Nov 2022, 00:00 GMT · active
Contract
£1 · signed 1 Nov 2022, 00:00 GMT · active
Contract
£1 · signed 1 Nov 2022, 00:00 GMT · active
Contract
£1 · signed 1 Nov 2022, 00:00 GMT · active
Contract
£1 · signed 1 Nov 2022, 00:00 GMT · active
Contract
£1 · signed 1 Nov 2022, 00:00 GMT · active
Contract
£1 · signed 1 Nov 2022, 00:00 GMT · active
Contract
£1 · signed 1 Nov 2022, 00:00 GMT · active
Contract
£1 · signed 1 Nov 2022, 00:00 GMT · active
Bid statistics
bids: 34 (lot 1)
bids: 34 (lot 1)
bids: 34 (lot 1)
bids: 34 (lot 1)
bids: 34 (lot 1)
bids: 34 (lot 1)
bids: 34 (lot 1)
bids: 34 (lot 1)
bids: 34 (lot 1)
bids: 34 (lot 1)
bids: 34 (lot 1)
bids: 34 (lot 1)
bids: 34 (lot 1)
bids: 34 (lot 1)
bids: 34 (lot 1)
bids: 34 (lot 1)
bids: 34 (lot 1)
bids: 34 (lot 1)
electronicBids: 34 (lot 1)
electronicBids: 34 (lot 1)
electronicBids: 34 (lot 1)
electronicBids: 34 (lot 1)
electronicBids: 34 (lot 1)
electronicBids: 34 (lot 1)
electronicBids: 34 (lot 1)
electronicBids: 34 (lot 1)
electronicBids: 34 (lot 1)
electronicBids: 34 (lot 1)
electronicBids: 34 (lot 1)
electronicBids: 34 (lot 1)
electronicBids: 34 (lot 1)
electronicBids: 34 (lot 1)
electronicBids: 34 (lot 1)
electronicBids: 34 (lot 1)
electronicBids: 34 (lot 1)
electronicBids: 34 (lot 1)
foreignBidsFromEU: 1 (lot 1)
foreignBidsFromEU: 1 (lot 1)
foreignBidsFromEU: 1 (lot 1)
foreignBidsFromEU: 1 (lot 1)
foreignBidsFromEU: 1 (lot 1)
foreignBidsFromEU: 1 (lot 1)
foreignBidsFromEU: 1 (lot 1)
foreignBidsFromEU: 1 (lot 1)
foreignBidsFromEU: 1 (lot 1)
foreignBidsFromEU: 1 (lot 1)
foreignBidsFromEU: 1 (lot 1)
foreignBidsFromEU: 1 (lot 1)
foreignBidsFromEU: 1 (lot 1)
foreignBidsFromEU: 1 (lot 1)
Buyer and organisations in this procedure

NHS England

Contracting authority GB-FTS-3022
View buyer profile

  • NHS England
    buyer
    centralPurchasingBody

    Quarry House, Quarry Hill, Leeds, UK, LS2 7UE
    david.ford1@nhs.net

  • Accord-UK Ltd
    supplier

    Barnstaple, UK

  • Amarox Limited
    supplier

    Harrow, UK

  • Ascend Laboratories UK Ltd
    supplier

    Edgware, UK

  • Aspire Pharma Limited
    supplier

    Petersfield, UK

  • Cipla
    supplier

    London, UK

  • Colonis Pharma Ltd
    supplier

    Weybridge, UK

  • Dr.Reddy's Laboratories (UK) Limited
    supplier

    Cambridge, UK

  • Gerot Lannach UK Ltd
    supplier

    Ely, UK

  • Glenmark Pharmaceuticals Europe Limited
    supplier

    Watford, UK

  • Milpharm Ltd/aurobinbdo
    supplier

    South Ruislip, UK

  • Morningside Pharmaeuticals
    supplier

    Loughborough, UK

  • Mylan
    supplier

    Hatfield, UK

  • Pfizer Ltd
    supplier

    Tadworth, UK

  • Selective Supplies Ltd.
    supplier

    Watford, UK

  • Takeda UK Ltd
    supplier

    London, UK

  • Teva UK Limited
    supplier

    Castleford, UK

  • The High Court
    reviewBody

    Strand, London, WC2A 2LL
    generaloffice@administrativecourtoffice.justice.gov.uk

  • Thornton and Ross Ltd
    supplier

    Huddersfield, UK

  • Wockhardt UK Limited
    supplier

    Wrexham, UK
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published